GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » Valuation Rank

Diasorin SpA (Diasorin SpA) Valuation Rank


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Diasorin SpA Valuation Rank Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA (Diasorin SpA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » Valuation Rank
Comparable Companies
HKSE:01527 HKSE:08646 HKSE:01273 HKSE:08609 HKSE:01416 HKSE:08257 HKSE:01152 HKSE:08510 HKSE:08070 HKSE:01591 TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT
Traded in Other Exchanges
DIA:Italy 0GZX:UK 34D:Germany
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Website
https://www.diasoringroup.com
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.